I'm most interested in the results of the second B-UP cohort as that appears to be the only likely upside driver in Q1. It's possible we see B-OM interim results in Q1 but I'm betting on Q2. If the second cohort of B-UP is great and the price responds we could be on our way. If not I think it gives safety to the shorts for a couple more months. Still, I'd much rather be long than short at this juncture regardless of the results.
I still believe we will see the Prurisol partnership in Q4 2017 - Q1 2018.
I'm very skeptical that we will see a Brilacidin partnership in 2017 but would love to see it happen.
All content of my posts is my opinion and speculation. Do not treat anything I say as fact or actionable investment advice. I participate to challenge my investment thesis from any angle possible. Please do your own due diligence.